Tuesday 22 March | |
Unilever PLC | dividend payment date |
Wednesday 23 March | |
no events scheduled | |
Thursday 24 March | |
British American Tobacco PLC | ex-dividend date |
Close Brothers Group PLC | ex-dividend date |
CLS Holdings PLC | ex-dividend date |
Craneware PLC | ex-dividend date |
Ferguson PLC | ex-dividend date |
Greggs PLC | special ex-dividend date |
IDOX plc | ex-dividend date |
Jersey Electricity PLC | dividend payment date |
Mid Wynd International Investment Trust PLC | ex-dividend date |
Nichols PLC | ex-dividend date |
OSB Group PLC | ex-dividend date |
Palace Capital PLC | ex-dividend date |
Pearson PLC | ex-dividend date |
Prudential PLC | ex-dividend date |
Schroders PLC | ex-dividend date |
Volution Group PLC | ex-dividend date |
XP Power Ltd | ex-dividend date |
Friday 25 March | |
BP PLC | dividend payment date |
City of London Investment Group PLC | dividend payment date |
City of London Investment Group PLC | special dividend payment date |
Dunedin Enterprise Investment Trust PLC | dividend payment date |
Empiric Student Property PLC | dividend payment date |
Foresight Group Holdings Ltd | dividend payment date |
FRP Advisory Group PLC | dividend payment date |
Henderson Opportunities Trust PLC | dividend payment date |
Honeycomb Investment Trust PLC | dividend payment date |
JLEN Environmental Assets Group Ltd | dividend payment date |
Jupiter Emerging & Frontier Income Trust PLC | dividend payment date |
LXI REIT PLC | dividend payment date |
Mattioli Woods PLC | dividend payment date |
Real Estate Credit Investments Ltd | dividend payment date |
RM Infrastructure Income PLC | dividend payment date |
Ruffer Investment Co Ltd | dividend payment date |
Schroder Real Estate Investment Trust Ltd | dividend payment date |
Triple Point Social Housing REIT PLC | dividend payment date |
Utilico Emerging Markets Trust PLC | dividend payment date |
Monday 28 March | |
AstraZeneca PLC | dividend payment date |
Diversified Energy Co PLC | dividend payment date |
Mountview Estates PLC | dividend payment date |
Copyright 2022 Alliance News Limited. All Rights Reserved. |
![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd
AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.
Read more